tiprankstipranks
Advertisement
Advertisement

LRMR Stock Latest News

LRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsLRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2d ago
LRMR
Nomlabofusp’s Manageable Risk, Strong Efficacy Signals, and Significant FA Market Upside Underpin Buy Rating on LRMR
PremiumRatings
Nomlabofusp’s Manageable Risk, Strong Efficacy Signals, and Significant FA Market Upside Underpin Buy Rating on LRMR
1M ago
LRMR
Larimar Therapeutics price target raised to $13 from $12 at Wedbush
PremiumThe Fly
Larimar Therapeutics price target raised to $13 from $12 at Wedbush
2M ago
LRMR
Larimar Therapeutics: Undervalued First-in-Class Frataxin Replacement with Favorable Regulatory Path and 2026 Inflection Point
PremiumRatings
Larimar Therapeutics: Undervalued First-in-Class Frataxin Replacement with Favorable Regulatory Path and 2026 Inflection Point
2M ago
LRMR
Larimar Therapeutics reports Q4 EPS (73c), consensus (55c)
PremiumThe Fly
Larimar Therapeutics reports Q4 EPS (73c), consensus (55c)
2M ago
LRMR
LRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsLRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
LRMR
Larimar Advances Nomlabofusp Toward 2026 BLA Submission
Premium
Company Announcements
Larimar Advances Nomlabofusp Toward 2026 BLA Submission
2M ago
8K
LRMR
Larimar Therapeutics price target raised to $12 from $11 at Wedbush
Premium
The Fly
Larimar Therapeutics price target raised to $12 from $11 at Wedbush
2M ago
LRMR
Larimar Therapeutics Announces Upsized Public Equity Offering
PremiumCompany Announcements
Larimar Therapeutics Announces Upsized Public Equity Offering
2M ago
8K
LRMR
Larimar Therapeutics 20M share Spot Secondary priced at $5.00
PremiumThe Fly
Larimar Therapeutics 20M share Spot Secondary priced at $5.00
2M ago
LRMR
Larimar Therapeutics $75M Spot Secondary price range $4.75-$5.25
PremiumThe Fly
Larimar Therapeutics $75M Spot Secondary price range $4.75-$5.25
2M ago
LRMR
Larimar Therapeutics price target raised to $14 from $12 at Citi
PremiumThe Fly
Larimar Therapeutics price target raised to $14 from $12 at Citi
2M ago
LRMR
Midday Fly By: Home Depot reports Q4 beat, AMD and Meta expand partnership
PremiumThe FlyMidday Fly By: Home Depot reports Q4 beat, AMD and Meta expand partnership
2M ago
HD
AMD
Larimar Therapeutics announces FDA granted BTD to nomlabofusp
Premium
The Fly
Larimar Therapeutics announces FDA granted BTD to nomlabofusp
2M ago
LRMR
FDA Grants Breakthrough Therapy Status to Larimar’s Nomlabofusp
Premium
Company Announcements
FDA Grants Breakthrough Therapy Status to Larimar’s Nomlabofusp
2M ago
8K
LRMR
Larimar’s Pediatric Friedreich’s Ataxia Trial Termination: What Investors Should Know
PremiumCompany Announcements
Larimar’s Pediatric Friedreich’s Ataxia Trial Termination: What Investors Should Know
3M ago
LRMR
Larimar Therapeutics executes preferred stock exchange and amendment
PremiumCompany Announcements
Larimar Therapeutics executes preferred stock exchange and amendment
3M ago
8K
LRMR
Larimar advances nomlabofusp toward accelerated Friedreich’s ataxia approval
PremiumCompany Announcements
Larimar advances nomlabofusp toward accelerated Friedreich’s ataxia approval
4M ago
8K
LRMR
Larimar Therapeutics Executes Strategic Stock Exchange Agreement
PremiumCompany Announcements
Larimar Therapeutics Executes Strategic Stock Exchange Agreement
5M ago
8K
LRMR
Larimar Therapeutics Highlights Promising Friedreich’s Ataxia Data
PremiumCompany AnnouncementsLarimar Therapeutics Highlights Promising Friedreich’s Ataxia Data
6M ago
8K
LRMR
Larimar Therapeutics Shows Promise in Friedreich’s Ataxia Treatment
Premium
Company Announcements
Larimar Therapeutics Shows Promise in Friedreich’s Ataxia Treatment
6M ago
LRMR
Buy Rating for Larimar Therapeutics: Optimism in Frataxin Replacement Therapy Despite Safety Concerns
Premium
Ratings
Buy Rating for Larimar Therapeutics: Optimism in Frataxin Replacement Therapy Despite Safety Concerns
6M ago
LRMR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >